Analyst Reco. Outset Medical, Inc.

Equities

OM

US6901451079

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
2.38 ^USD	-6.67%		+5.78%	-56.01%

Apr. 17	Outset Medical and U.S. Renal Care Announce Multi-Year Agreement to Accelerate and Grow Home Dialysis Across the U.S	CI
Apr. 08	BTIG Initiates Outset Medical at Buy Rating With $6 Price Target	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BTIG Initiates Outset Medical at Buy Rating With $6 Price Target	Apr. 08	MT
RBC Reduces Price Target on Outset Medical to $5 From $6, Keeps Sector Perform Rating	Feb. 22	MT
RBC Downgrades Outset Medical to Sector Perform From Outperform, Slashes Price Target to $6 From $14	Jan. 12	MT
Morgan Stanley Raises Outset Medical Price Target to $5.50 From $5, Maintains Equal Weight Rating	Dec. 04	MT
Morgan Stanley Cuts Price Target on Outset Medical to $5 From $19, Maintains Equalweight Rating	Nov. 14	MT
TD Cowen Cuts Outset Medical Price Target to $9 From $32, Maintains Outperform Rating	23-10-13	MT
Stifel Cuts Price Target on Outset Medical to $6 From $26, Maintains Buy Rating	23-10-13	MT
BofA Securities Downgrades Outset Medical to Underperform From Buy	23-10-13	MT
Outset Medical Receives Price Target Reduction to $17 From $29 From RBC, Shares Fall Pre-Bell After Revenue Guidance Cut, Outperform Kept	23-10-13	MT
Morgan Stanley Adjusts Price Target on Outset Medical to $19 From $22, Maintains Equalweight Rating	23-08-24	MT
CL King Initiates Outset Medical With Neutral Rating	23-08-17	MT
Morgan Stanley Trims Price Target on Outset Medical to $22 From $23, Maintains Equal-Weight Rating	23-08-03	MT
Morgan Stanley Cuts Price Target on Outset Medical to $23 From $27, Maintains Equalweight Rating	23-05-31	MT
RBC Cuts Price Target on Outset Medical to $29 From $32, Maintains Outperform Rating	23-05-04	MT
RBC Lifts Price Target on Outset Medical to $32 From $31 'to Better Reflect Market Multiples,' Maintains Outperform Rating	23-02-14	MT
Morgan Stanley Adjusts Price Target on Outset Medical to $27 From $17, Maintains Equal-Weight Rating	23-01-06	MT
RBC Initiates Outset Medical at Outperform With $23 Price Target, Says Stock 'Significantly Undervalued' Given Opportunities Ahead	22-11-11	MT
Morgan Stanley Trims Price Target on Outset Medical to $17 From $19, Maintains Equalweight Rating	22-11-10	MT
Goldman Sachs Adjusts Price Target on Outset Medical to $29 From $34, Maintains Buy Rating	22-11-09	MT
Morgan Stanley Adjusts Outset Medical's Price Target to $19 from $22, Retains Equalweight Rating	22-10-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Outset Medical, Inc.

Equities

OM

US6901451079

Analyst Reco.

Filters